VYVGART Hytrulo
NDC 73475-3102, efgartigimod alfa and hyaluronidase (human recombinant), injection, solution, from argenx US.
- Product NDC
- 73475-3102
- Status
- Listed
- Labeler
- argenx US
- Dosage form
- INJECTION, SOLUTION
- Route
- SUBCUTANEOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- BLA
- Application
- BLA761304
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/73475-3102 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- EFGARTIGIMOD ALFA180 mg/mL
- HYALURONIDASE (HUMAN RECOMBINANT)2000 U/mL
Pharmacologic classes
Endoglycosidase [EPC]; Glycoside Hydrolases [CS]; Neonatal Fc Receptor Blocker [EPC]; Neonatal Fc Receptor Blockers [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 73475-3102-3 | 73475310203 | 1 VIAL, SINGLE-DOSE in 1 CARTON (73475-3102-3) / 5.6 mL in 1 VIAL, SINGLE-DOSE |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/7104d9e5-9910-47f5-9a93-741ac50f43b6Medicare Part B payment limits (ASP)
GET /v1/drugs/asp?ndc=73475-3102
Use it
Look up 73475-3102 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/73475-3102 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 73475-3102. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.